posity. 8, 9 Because each of these variants typically exerts only a small effect on BMI, to obtain a more powerful predictor, one common approach is to combine multiple variants into a single genetic risk score whereby all obesity-predisposing alleles that a person carries are added up in a weighted sum, with weights proportional to their effect sizes. Chatterjee and colleagues used 2 genetic predictors of BMI: a variant in the fat mass and obesityassociated (FTO) gene and a BMI gene score comprising 39 BMI-associated single-nucleotide polymorphisms identified by previous genome-wide association studies. 8, 9 They first confirmed that both genetic instruments were associated with increased BMI. In a meta-analysis of several prospective studies including 51 646 individuals of European ancestry, they showed that each unit increase in the genetic risk score was associated with an average increase in BMI of 1.05 kg/m 2 . They next showed that the same 1-unit increase in the genetic risk score was associated with an 11% increase in the risk of incident AF, lending support to the hypothesis that obesity is causally related to incident AF.
Although Mendelian randomization provides a powerful approach to strengthen the conclusions of observational studies, it has several limitations. First, as noted above, the validity of the method relies on the assumption that genotype is unrelated to any factors that could confound the exposure-outcome relationship. Although this assumption is often untestable, empirical evidence suggests that it is plausible in many situations. 10 For example, a previous study 11 found no association between BMI-associated variants and several traditional risk factors of cardiovascular disease. On the other hand, an earlier study showed that a closely linked FTO variant was associated with blood pressure and concluded that obesity was causally related to hypertension. 12 This alone does not invalidate the use of FTO variants as genetic instruments for testing the causal relationship between BMI and AF. On the contrary, this suggests that if hypertension is a direct consequence of obesity rather than a correlate, adjusting for it could obscure the true causal role of obesity. Similar arguments may be made for other AF risk factors such as sleep apnea. Nevertheless, adjustment for hypertension and other risk factors did not alter the associations between genotype and AF in the present study. Conversely, the association between genetic variants and AF was completely attenuated after accounting for measured BMI, further supporting the notion that the relationship was causally mediated by BMI, rather than through alternative pathways, as a result of pleiotropy (the effect of a particular gene on multiple risk factors) or linkage disequilibrium (statistical association between different genetic variants induced by the tendency of alleles that are close together on a chromosome to be inherited together). Second, weak genetic instruments, which explain too little variation in the exposure, could bias causal estimates or result in failure to establish causal relationships owing to a lack of power. A recent article described this situation as analogous to interpreting the effects of a lipid-lowering trial on coronary heart disease when the therapy studied (such as niacin or fibrates) has a weak effect on lowering low-density lipoprotein cholesterol. 13 The large sample size and the use of a genetic score including multiple single-nucleotide polymorphisms robustly associated with BMI partially alleviate this concern.
What are the implications of these findings? Although the study provides strong support for the causal role of obesity in the development of AF, the estimate of causal effect size should be interpreted with caution and should not be extrapolated to other situations. Estimates from Mendelian randomization studies are likely to be different from the effects of weight-loss interventions for several reasons. First, Mendelian randomization estimates represent the effect of lifelong differences in BMI, whereas most interventions are applied to individuals for a limited duration of time. In this respect, it is interesting to note that the causal effect of genetically determined BMI on AF (≈10% increase in AF risk for a 1-unit increase in genetically determined BMI) was larger in magnitude than (but not statistically different from) the observational association between measured BMI and incident AF (5% increase in AF risk for a 1-unit increase in measured BMI), suggesting that genotype may better reflect the effects of cumulative exposure to increased BMI compared with cross-sectional assessments. Second, causal effect estimates from Mendelian randomization studies can be thought of as a population-average effect (ie, as if the intervention were applied to the entire population) and could be different from the effect of interventions applied to specific subgroups. For example, a recent analysis of the SOS trial (Swedish Obese Subjects) demonstrated that an average weight loss of 18% or nearly 50 lb through bariatric surgery reduced the risk of AF by 29%.
14 On the basis of the present study, however, a similar reduction in risk should be achieved with only an ≈3-point reduction in BMI, corresponding to a weight loss of 15 to 25 lb (depending on one's height). Furthermore, it is not known whether obesity-mediated risk for AF is affected by body fat distribution, which has recently been shown to be a strong determinant of cardiovascular risk independently of BMI, 15 or if it might be modified by behavioral factors such as nutrition and physical activity. Only future randomized controlled trials can establish the true magnitude of AF risk reduction resulting from weight loss in different patient groups. Nevertheless, the data provided by Chatterjee and colleagues suggest that early prevention of obesity is likely to have a greater impact in reducing the risk of AF and should be a focus of public health interventions.
It is important to note that although Mendelian randomization studies use genetic variants as a proxy for an exposure, their main goal is not to identify genetic determinants of disease, which might be used for genetic screening, but to provide insight into the role of modifiable (nongenetic) exposures in disease etiology. 6, 7 As has recently been demonstrated, improving one's environment with lifestyle behaviors such as increased physical activity and a healthy diet can decrease the risk of heart disease regardless of one's inherent genetic risk. 16 Whereas genetic variants can contribute to interindividual differences in BMI, they cannot explain the expanding obesity epidemic over recent decades because the genetic makeup of the population could not have changed over a span of 2 or 3 generations. Thus, lifestyle interventions directed at primary prevention of obesity may be the best way to reduce the growing prevalence of AF. Although our genetic predispositions for obesity are predetermined at birth, they do not have to define our destiny for disease. It remains within ourselves to alter that destiny through a healthy lifestyle and avoidance of weight gain. 
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